Basel, July 2, 2026 – Novartis today announced that the European Commission (EC) has approved Itvisma ® (onasemnogene ...

About Novartis Immunology At Novartis, we’re advancing bold science for autoimmune diseases, where meaningful therapeutic progress has long stalled. With a growing legacy of first-in-class innovation ...

You can break new ground in how we bring treatments to patients when you join us in Sales. Collaborating closely with Marketing, Access and Medical teams, you’ll educate healthcare professionals about ...

Animal research is key to many of the great medical advances of today, including cancer treatments; medicines to treat neurological diseases such as multiple sclerosis, medicines for diseases that ...

Brochure "Explanations of the Board of Directors on the Amendment of the Articles of Incorporation" English (PDF 0.1 MB) Deutsch (PDF 0.2 MB) Français (PDF 0.1 MB) Statement regarding Agenda Item 6.1 ...

The need to improve access to medicines remains one of the world’s greatest healthcare challenges. Through the Novartis Access Principles, we are committed to expanding access to our medicines to ...

Transforming the treatment and healthcare system landscape using early interventions, pioneering treatments, and innovative partnerships to avoid preventable mortality from cardiovascular disease (CVD ...

With new tools and approaches comes broader opportunity to benefit patients. Cardiovascular and metabolic diseases are responsible for nearly 18 million deaths worldwide each year and represent a huge ...

Continuously rising dividend since 1996 Shareholders approved the 29th consecutive dividend increase per share since the creation of Novartis in 1996, with an increase of 5.7% to CHF 3.70 per share ...

Our purpose at Novartis is to reimagine medicine to extend and improve people’s lives. To reflect this, we embrace pioneering collaborations and partner with external scientific experts to mutually ...

Awareness and training programs are offered regularly in a range of formats, including awareness-building programs, e-training, face-to-face programs, games and workshops. We provide extensive ...